Alcon Inc.
ALCHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeAlcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The $32.02B market capitalization puts ALC squarely in large-cap range for its industry. The company operates through two segments, Surgical and Vision Care.
Market Cap
$32.02B
Beta
0.70
P/E (TTM)
39.32
P/E (Fwd)
16.56
EPS (TTM)
$1.67
EPS (Fwd)
$3.96
ROE
3.7%
ROA
2.5%
Cash
$1.66B
Total Debt
$5.26B
Free CF
$1.19B
52W Change
-23.6%
Annual Financials
Cash vs Debt
The company holds $1.66B in cash, though total debt stands at $5.26B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $1.19B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 3.7%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.5% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $8.72B to $10.40B.
With a beta below 0.7, Alcon Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Alcon Inc.'s trajectory.